IT1271354B - Preparation of a pharmaceutical form capable of combating hyperinsulinism - Google Patents
Preparation of a pharmaceutical form capable of combating hyperinsulinismInfo
- Publication number
- IT1271354B IT1271354B ITMI931104A ITMI931104A IT1271354B IT 1271354 B IT1271354 B IT 1271354B IT MI931104 A ITMI931104 A IT MI931104A IT MI931104 A ITMI931104 A IT MI931104A IT 1271354 B IT1271354 B IT 1271354B
- Authority
- IT
- Italy
- Prior art keywords
- hyperinsulinism
- combating
- preparation
- pharmaceutical form
- form capable
- Prior art date
Links
- 201000008980 hyperinsulinism Diseases 0.000 title abstract 3
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 2
- 229960004308 acetylcysteine Drugs 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
N-acyl-cysteines and their analogues, for example N- acetyl cysteine, its esters or salts, are useful in the treatment of hyperinsulinism. The administration of N-acetyl cysteine, even as a single drug, in doses between 100 and 5000 mg/day significantly reduces hyperinsulinism and the disease condition associated therewith.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI931104A IT1271354B (en) | 1993-05-28 | 1993-05-28 | Preparation of a pharmaceutical form capable of combating hyperinsulinism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI931104A IT1271354B (en) | 1993-05-28 | 1993-05-28 | Preparation of a pharmaceutical form capable of combating hyperinsulinism |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI931104A0 ITMI931104A0 (en) | 1993-05-28 |
| ITMI931104A1 ITMI931104A1 (en) | 1994-11-28 |
| IT1271354B true IT1271354B (en) | 1997-05-27 |
Family
ID=11366278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI931104A IT1271354B (en) | 1993-05-28 | 1993-05-28 | Preparation of a pharmaceutical form capable of combating hyperinsulinism |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1271354B (en) |
-
1993
- 1993-05-28 IT ITMI931104A patent/IT1271354B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI931104A1 (en) | 1994-11-28 |
| ITMI931104A0 (en) | 1993-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI944035A (en) | Tramadol salt-containing drug with delayed release of the active substance | |
| CA2240329A1 (en) | Improved delivery of multiple doses of medications | |
| KR930702022A (en) | Treatment or prevention of type 1 diabetes by oral administration of insulin | |
| GR3007202T3 (en) | ||
| ZA924772B (en) | Delayed therapy | |
| AU2584192A (en) | Bone-growth-stimulating composition | |
| AU6060896A (en) | Oral 1alpha-hydroxyprevitamin D | |
| BR122012014331A8 (en) | PHARMACEUTICAL FORMULATIONS | |
| GEP20012549B (en) | Pharmaceutical Composition Containing Sumatriptan | |
| CA2301057A1 (en) | A method of administering liposomal encapsulated taxane | |
| EP0513702A3 (en) | Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| EP0375628A3 (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment | |
| EP0620004A4 (en) | Medicinal composition. | |
| AU1277792A (en) | Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts | |
| NZ225526A (en) | Odourless and tasteless tablets for the treatment of uraemia | |
| CA2180178A1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
| GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
| IT1271354B (en) | Preparation of a pharmaceutical form capable of combating hyperinsulinism | |
| GB9420748D0 (en) | 1,5 benzodiazepine derivatives | |
| AU3080192A (en) | Peroral administration form for peptidic medicaments, in particular insulin | |
| EP0334177A3 (en) | Pharmaceutical product for oral administration, particularly for the iron and magnesium substitution therapy | |
| IT1267664B1 (en) | Therapeutic use of phosphocreatin | |
| IT1255380B (en) | Nitrobenzoyl alanines, process for their preparation, their use as therapeutic agents and pharmaceutical compositions containing them | |
| IT1251993B (en) | Pharmaceutical compositions for oral use based on internal ganglioside esters for the treatment of neural diseases of the peripheral nervous system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970825 |